Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
Open Access
- 23 August 2023
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 20 (6) , 1508-1528
Abstract
No abstract availableKeywords
Funding Information
- Akademiska Sjukhuset
- Medical Research Council (G0802251, R005036/1)
- NIHR Cambridge Biomedical Research Centre
- Uppsala University
This publication has 135 references indexed in Scilit:
- The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trialJournal of Neuroinflammation, 2014
- Principal Component Analysis of the Cytokine and Chemokine Response to Human Traumatic Brain InjuryPLOS ONE, 2012
- BDNF Polymorphism Predicts General Intelligence after Penetrating Traumatic Brain InjuryPLOS ONE, 2011
- Physiology of MicrogliaPhysiological Reviews, 2011
- Diffuse Traumatic Axonal Injury in the Mouse Induces Atrophy, c-Jun Activation, and Axonal Outgrowth in the Axotomized Neuronal PopulationJournal of Neuroscience, 2011
- High-mobility group box 1 (HMGB1) as a master regulator of innate immunityCell and tissue research, 2010
- The Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and Evidence for Cerebral Parenchymal ProductionJournal of Cerebral Blood Flow & Metabolism, 2010
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2009
- Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injuryNeuroscience Letters, 2005